# An Investigator Initiated Prospective, Four Arms Randomized Comparative Study of Efficacy and Safety of Saroglitazar, Vitamin E and Life Style Modification in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)/ Non-alcoholic Steatohepatitis (NASH)

> **NCT04193982** · PHASE3 · UNKNOWN · sponsor: **Asian Institute of Gastroenterology, India** · enrollment: 250 (estimated)

## Conditions studied

- NAFLD

## Interventions

- **DRUG:** Saroglitazar
- **DRUG:** Vitamin E
- **DRUG:** Combination drug
- **BEHAVIORAL:** Lifestyle Changes

## Key facts

- **NCT ID:** NCT04193982
- **Lead sponsor:** Asian Institute of Gastroenterology, India
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-31
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-10-31
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2021-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04193982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04193982, "An Investigator Initiated Prospective, Four Arms Randomized Comparative Study of Efficacy and Safety of Saroglitazar, Vitamin E and Life Style Modification in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)/ Non-alcoholic Steatohepatitis (NASH)". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT04193982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*